You are here

Home

Clinical Trials: Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, October 1, 2021 - 12:00
MABs Therapy m.3243A>G Mutation Carriers
Condition:   Mitochondrial Myopathies
Intervention:   Biological: autologous mesoangioblasts
Sponsor:   Maastricht University
Recruiting
Posted: Thursday, September 23, 2021 - 12:00
Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury
Condition:   Spinal Cord Injury Cervical
Interventions:   Drug: WJ-MSC (XCEL-UMC-BETA);   Drug: Placebo
Sponsors:   Banc de Sang i Teixits;   Institut Guttmann;   Academic Research Organization (ARO) - VHIR
Not yet recruiting
Posted: Thursday, September 2, 2021 - 12:00
Cell Therapy for IBM by Muscle Injection of ADSVF: a Phase I Trial
Condition:   Inclusion Body Myositis
Intervention:   Biological: ADSVF
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI
Condition:   Traumatic Brain Injury
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intrathecal Injection for SCI
Condition:   Spinal Cord Injuries
Intervention:   Biological: autologous adipose derived mesenchymal stem cells
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP
Condition:   Cerebral Palsy
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP
Condition:   Cerebral Palsy
Intervention:   Biological: autologous adipose derived mesenchymal stem cells
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Tuesday, August 17, 2021 - 12:00
Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct
Condition:   Ischemic Stroke
Interventions:   Biological: Conditioned Medium;   Biological: Umbilical Cord Mesenchymal Stem Cells;   Procedure: Neurologic and Neutrophic Drugs
Sponsor:   PT. Prodia Stem Cell Indonesia
Not yet recruiting
Posted: Friday, August 13, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Thursday, August 12, 2021 - 12:00
Investigating the Potential Role of Aerosolized All-trans Retinoic Acid for Treating COVID-19 Anosmia and Regaining Sense of Smell.
Condition:   Post COVID-19 Anosmia (Loss of Smell)
Interventions:   Drug: Aerosolized All trans retinoic acid;   Drug: Placebo/Control
Sponsors:   Amr kamel khalil Ahmed;   Faculty of Medicine, Kafrelshiekh Univversity,Egypt.
Not yet recruiting

Pages